1 Iloprost and cicaprost (LP-receptor agonists) induced relaxations in the
histamine- (50 mu M) contracted human bronchial preparations (pD(2) values,
6.63+/-0.12 and 6.86+/-0.08; E-max values, 90+/-04 and 65+/-08% of the pap
averine response for iloprost (n=6) and cicaprost (n=3), respectively).
2 Prostaglandin E-2 (PGE(2)) and misoprostol (EP-receptor agonist) relaxed
the histamine-contracted human bronchial preparations (pD(2) values, 7.13+/
-0.07 and 6.33+/-0.28; E-max values, 67+/-04 and 57+/-08% of the papaverine
response for PGE(2) (n=14) and misoprostol (n=4), respectively). In additi
on, both relaxations were inhibited by AH6809 (DP/EP1/EP2-receptor antagoni
st; 3 mu M; n= 5-6).
3 The PGE(2)-induced relaxations of human bronchial preparations were not m
odified by treatment with AH23848B (TP/EP4-receptor antagonist; 30 mu M; n=
4).
4 The contracted human bronchial preparations were significantly relaxed by
prostaglandin D-2 (PGD(2)) or by BW245C a DP-receptor agonist. However, th
ese responses did not exceed 40% of the relaxation induced by papaverine. I
n addition, the relaxations induced by PGD(2) were significantly inhibited
by treatment with a DP-receptor antagonist BWA868C (0.1 mu M; n= 3).
5 These data suggest that the relaxation of human isolated bronchial prepar
ations induced bl prostanoids involved IP-, EP2- and to a lesser extent DP-
receptors but not EP4-receptor.